# Iterum Therapeutics plc — Form D

Iterum Therapeutics plc of DUBLIN, L2, a company, filed a Form D exempt-offering notice with the SEC on 2020-06-12. The offering totals $2.8M, of which $2.8M was reported sold. Industry: Pharmaceuticals.

## Offering

- Filed: 2020-06-12
- Form: D
- Accession: 0001659323-20-000002
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $2.8M
- Amount sold: $2.8M
- Investors: 8
- Date of first sale: 2020-06-05
- Revenue range: Decline to Disclose
- SEC file number: 021-368874

## Issuer

- Name: Iterum Therapeutics plc
- CIK: 0001659323
- Entity type: Corporation
- Jurisdiction: IRELAND
- Incorporated: 2015
- Address: BLOCK 2 FLOOR 3, HARCOURT CENTRE, DUBLIN, L2, 2
- Phone: (872) 225-6077

## Officers, directors & promoters (24)

| Name | Role | Location |
| --- | --- | --- |
| Ronald M Hunt | Director | New York, NY |
| James I Healy | Director | DORADO, PR |
| Shahzad M Malik | Director | Dublin, L2 |
| Judith M Matthews | Executive Officer | Dublin, L2 |
| Judith M Matthews | Promoter | Dublin, L2 |
| Michael M Dunne | Executive Officer | Dublin, L2 |
| Mark K Chin | Director | Dublin, L2 |
| Louise M Barrett | Executive Officer | Dublin, L2 |
| Brenton K Ahrens | Director | Dublin, L2 |
| Corey N Fishman | Director | Dublin, L2 |
| Corey N Fishman | Executive Officer | Dublin, L2 |
| Corey N Fishman | Promoter | Dublin, L2 |
| Patrick J Heron | Director | Menlo Park, CA |
| Mark I Chin | Director | Dublin, L2 |
| Michael W Dunne | Executive Officer | Dublin, L2 |
| Michael W Dunne | Promoter | Dublin, L2 |
| Robert I Hopfner | Director | Dublin, L2 |
| Shahzad I Malik | Director | Dublin, L2 |
| Jeff I Schaffnit | Executive Officer | Dublin, L2 |
| David I Kelly | Director | Dublin, L2 |
| Paul R Edick | Director | Dublin, L2 |
| Tracy I Saxton | Director | Dublin, L2 |
| Patrick N Heron | Director | Dublin, L2 |
| David M Kelly | Director | Westfield, MA |

## Other filings by this issuer (5)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2020-07-07](https://search.stillhousedata.com/formd/0001659323-20-000003) | D | $2.8M | $2.8M |
| [2018-03-02](https://search.stillhousedata.com/formd/0001659323-18-000001) | D/A | $78.1M | $78.1M |
| [2017-06-01](https://search.stillhousedata.com/formd/0001659323-17-000001) | D | $65.5M | $45.9M |
| [2016-12-30](https://search.stillhousedata.com/formd/0001659323-16-000002) | D/A | $47.6M | $47.6M |
| [2015-12-02](https://search.stillhousedata.com/formd/0001659323-15-000001) | D | $47.5M | $23.8M |

## More

- [CIK 1659323 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1659323&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001659323-20-000002.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.